Ticker brief
AXSM AXSOME THERAPEUTICS INC
Consumer, Non-cyclical · Biotechnology
last close
$145.04
1 day
-7.1%
14 days
-13.8%
mkt cap
$12.6B
signals 14d
8
authors 14d
4
crowd 14d
+0.5σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 52% mid · 80 pctile own 1y | IV/HV 1.19× |
| Skew — 25Δ RR 30d | +0.005 83 pctile own 1y | calls bid vs puts (call skew rich) |
| Net dealer OI (NDOI) | +1.24 normal | 5-session Δ -0.20 (as of 2026-07-16) |
| OI alarm | quiet | last alarm 2026-05-04 (z=2.5) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-02 → 2026-10-16 · now +0.55 (−1 bearish … +1 bullish)
Who spoke4
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Biotech2k1 | A | +1.11 | 4 | +0.26 |
| @Pharmdca | C | -3.41 | 2 | +0.35 |
| @_TP888 | C | +0.93 | 1 | -0.65 |
| @jeffsiegel | C | -1.44 | 1 | +0.25 |
Recent signals8of 8 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @Biotech2k1 | +0.55 | The author identifies high-quality biotech names trading at substantial discounts from their highs. | -7.7% | tweet ↗ |
| 2026-10-14 | @Biotech2k1 | +0.30 | Calls ARWR high quality and attractively valued while discussing alternative biotech selections. | -10.6% | tweet ↗ |
| 2026-10-13 | @Biotech2k1 | +0.40 | Calls AXSM and CYTK cheap while disclosing preference for MDGL and MIRM. | -7.2% | tweet ↗ |
| 2026-10-13 | @jeffsiegel | +0.25 | Frames a long-horizon thesis around Auvelity expansion into Alzheimer's. | -7.2% | tweet ↗ |
| 2026-10-08 | @_TP888 | -0.65 | Reports $114K of AXSM puts entirely executed at the ask. | -14.7% | tweet ↗ |
| 2026-10-08 | @Pharmdca | +0.45 | Names five commercial-stage biotech companies the author likes on pullbacks. | -14.7% | tweet ↗ |
| 2026-10-06 | @Pharmdca | +0.25 | Argues biotech is showing classic late-stage capitulation and bottom-forming conditions. | -16.8% | tweet ↗ |
| 2026-10-02 | @Biotech2k1 | -0.20 | Discloses retaining MDGL over AXSM based on pipeline quality and valuation. | -19.1% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.